<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Week 1 HW: Final Project Ideas :: 2026a-madeline-eibner-gebhardt</title><link>https://pages.htgaa.org/2026b/madeline-eibner-gebhardt/week-01-hw-project-ideas/index.html</link><description>(1) What you would like to biomanufacture and why? An often-quoted estimate predicts that antibiotic resistant infections will outpace cancer and heart disease as the global leading cause of death by 2050. Resistant bacteria are especially prevalent in hospital settings, where high antibiotic concentrations and large, diverse populations of pathogenic bacteria combine (within infected patients, in drains, etc) to drive rapid resistance evolution. Resistant bacteria are difficult to eliminate not only because 1), they, by definition, cannot be treated via traditional antibiotics, but also because, 2), they tend to form dense, sticky, and highly resilient biofilms. I want to biomanufacture something that combats antibiotic resistant pathogens – possibly via a phage-therapy based approach, taking advantage of automated and cloud-lab systems to design, engineer, and test a variety of modified phage at a large scale and create/identify promising anti-biofilm candidates against various bacterial pathogens.</description><generator>Hugo</generator><language>en</language><atom:link href="https://pages.htgaa.org/2026b/madeline-eibner-gebhardt/week-01-hw-project-ideas/index.xml" rel="self" type="application/rss+xml"/></channel></rss>